The trial started in June 2025 with an estimated enrollment of 57 participants across locations in Australia, Moldova, and New Zealand, with primary completion estimated for January 2026 and full study completion by November 2026, though results are not yet available as the study is currently in the recruiting Phase
The adjusted hazard ratio (aHR) for chronic cough for a GLP-1RA compared with any second-line non-GLP-1 RA medication was 1.12 (95% CI
This benefit is particularly useful for individuals engaged in intense physical training
We serve patients across Lee County and surrounding areas, including Fort Myers, North Fort Myers, Lehigh Acres, Bonita Springs, Estero, Naples, Punta Gorda, Sanibel, Fort Myers Beach, and Port Charlotte
As a GLP-1 receptor agonist, semaglutide mimics the incretin hormone GLP-1, increasing insulin release, decreasing glucagon levels, and slowing gastric emptying
Cilt btnln koruyan bu bileen yalanma kart etki gsterebilir